A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

Exclusion criteria

• ✕. After inquiry, it is found that there is a history of rabies vaccination or the use of passive immunization preparations for rabies virus.
• ✕. There was a history of injury from rabies virus-susceptible animals (such as cats and dogs) before the first dose of vaccination;
• ✕. The axillary body temperature of the participants on the day of enrollment was ≥37.3℃\*;
• ✕. Those whose various examination results during the screening period are abnormal and are determined by clinicians to be of clinical significance;
• ✕. Women who have a positive urine pregnancy test before vaccination (on the day of vaccination), or who, after assessment, cannot rule out the possibility of pregnancy or are breastfeeding;
• ✕. Hypertension that cannot be controlled by medication, such as systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg for participants aged 18 years and above before enrollment;
• ✕. Allergy to any component of the vaccine used in the test, such as human albumin, sucrose, or maltose;
• ✕. Those with a history of severe allergies in the past, such as anaphylactic shock, allergic laryngeal edema, allergic purpura, local allergic necrosis reaction (Arthus reaction), severe urticaria, allergic bronchitis, acquired angioedema, etc.